SL
YARW icon

Siren LLC’s Yarrow Bioscience YARW Stock Holding History

Siren LLC’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$15.2M Buy
+675,000
New +$23M 0.36% 56

Other funds holding YARW

Silverarc Capital Management
Silverarc Capital Management Boston, Massachusetts $854M AUM 179.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Monashee Investment Management
Monashee Investment Management Boston, Massachusetts $33.4M AUM 92.4% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $92B AUM 22.91% 1-Year Est. Return
Aster Capital Management
Aster Capital Management Dubai, United Arab Emirates $275M AUM 18.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return
MB, Levis & Associates
MB, Levis & Associates Center Valley, Pennsylvania $273M AUM 8.08% 1-Year Est. Return
Hurley Capital
Hurley Capital New York $206M AUM 18.12% 1-Year Est. Return

Siren LLC's YARW Position: Q3 2026 in Review

Siren LLC opened a new position in Yarrow Bioscience (YARW) in Q3 2026: 675,000 shares worth $15.2M. The stake represents 0.36% of the portfolio and ranks #56 among its holdings.

12 funds tracked by Wall St. Rank hold YARW as of Q3 2026.

  • Siren LLC held 675,000 shares of Yarrow Bioscience worth $15.2M as of Q3 2026.
  • Yarrow Bioscience was a new Siren LLC position in Q3 2026.
  • Yarrow Bioscience made up 0.36% of Siren LLC's portfolio in Q3 2026, its #56 holding.
  • 12 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q3 2026.

Based on Siren LLC's 13F filing for Q3 2026, filed 12 Nov 2026.